Atlas Oncology Partners
PrivateLast Round
Series A
Feb 25, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Atlas Oncology Partners is a healthcare services company that provides a value-based oncology enablement platform by embedding interdisciplinary care teams into community oncology practices and assuming full medical cost risk.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atlas Oncology Partners Comparables
Compare Atlas Oncology Partners with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thyme Care | 80% | |
| Cencora | 74% | |
| Evolent Health | 71% |
Atlas Oncology Partners Funding Rounds
Historical fundraising activity
Atlas Oncology Partners Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flare Capital Partners | Series A |
| Rubicon Founders | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2026
Open roles increased to 16, 107% of headcount.
- Sep 14, 2026
Open roles increased to 14, 93% of headcount.
Atlas Oncology Partners Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Atlas Oncology Partners's valuation, stock price, and market status.
Is Atlas Oncology Partners a public or private company?
Atlas Oncology Partners is a private company.
What is the current stock price of Atlas Oncology Partners?
Atlas Oncology Partners is a private company, so its shares have no public market price. Caplight tracks Atlas Oncology Partners's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Atlas Oncology Partners worth (valuation)?
Valuation information for Atlas Oncology Partners is not publicly available.
Can I buy Atlas Oncology Partners stock?
Atlas Oncology Partners shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Atlas Oncology Partners's last funding round?
Atlas Oncology Partners's most recent funding round was Series A on February 25, 2026.
Who are the main investors in Atlas Oncology Partners?
Key investors in Atlas Oncology Partners include Flare Capital Partners.
Will Atlas Oncology Partners IPO soon?
No public IPO plans have been announced for Atlas Oncology Partners.
How can I track Atlas Oncology Partners secondary market activity?
Caplight tracks bids, offers, and trades in Atlas Oncology Partners's shares on secondary markets.